Barclays Sticks to Their Hold Rating for GlaxoSmithKline (GSK)
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.
Novo Nordisk (0QIU) Gets a Buy from J.P. Morgan
In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a ...
Future Market Insights10h
Global Non-Small Cell Lung Carcinoma (NSCLC) Market Aims for USD 21.40 Billion Valuation by 2033, Fueled by a Solid 10% CAGR
The Global Non-Small Cell Lung Carcinoma (NSCLC) Market is on the brink of an extraordinary transformation, with market ...
Roche Expected to Report Higher Sales; Refined Pipeline in Focus -- Earnings Preview
SALES FORECAST: The Swiss pharma giant's third-quarter sales are forecast at 14.89 billion Swiss francs ($17.22 billion), according to a consensus of 11 analysts' estimates compiled by Visible Alpha.